Search results for "Colorectal Neoplasms."

showing 10 items of 431 documents

Virtual chromoendoscopy with iSCAN as an alternative method to dye-spray chromoendoscopy for dysplasia detection in long-standing colonic inflammator…

2021

Patients with long-standing colonic inflammatory bowel disease (cIBD) are at increased risk of developing colorectal cancer (CRC). Dye-spray chromoendoscopy (DCE) with targeted biopsies is the preferred technique for surveillance of dysplasia. Virtual chromoendoscopy (VCE) are arising to improve detection rates and adherence to surveillance guidelines, although its role is not yet well defined. The purpose of this study is to assess the effectiveness of VCE with iSCAN as an alternative method for dysplasia detection in cIBD.Retrospective case-control study with 191 patients included, 98 in the DCE (Indigo carmine) group and 93 in the VCE (iSCAN, twin-mode 1-3) group. The dysplasia detection…

medicine.medical_specialtyColorectal cancerColonoscopyInflammatory bowel diseaseGastroenterologyChromoendoscopy03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansColoring Agentsskin and connective tissue diseasesEarly Detection of CancerRetrospective StudiesAlternative methodsmedicine.diagnostic_testbusiness.industryGastroenterologyCase-control studyColonoscopyInflammatory Bowel Diseasesmedicine.diseasedigestive system diseasesIncreased riskDysplasiaCase-Control Studies030220 oncology & carcinogenesisColitis Ulcerative030211 gastroenterology & hepatologyColorectal NeoplasmsbusinessScandinavian Journal of Gastroenterology
researchProduct

Cost-effectiveness of screening for colorectal cancer in France using a guaiac test versus an immunochemical test

2010

Objectives: The aim of this study was to compare the cost and the effectiveness of two biennial fecal occult blood screening tests for colorectal cancer: a guaiac nonrehydrated test (G-FOBT) and an immunochemical test (I-FOBT) with the absence of screening.Methods: A Markov model was developed to compare these strategies in a general population of subjects aged 50 to 74 over a 20-year period.Results: Compared with the absence of screening, G-FOBT and I-FOBT were associated with a decrease in colorectal cancer mortality of 17.4 percent and 25.2 percent, respectively. With regard to cost-effectiveness, expressed as cost per life-year gained, I-FOBT was the most effective and most costly alter…

medicine.medical_specialtyColorectal cancerCost effectivenessCost-Benefit Analysishealth care facilities manpower and serviceseducationPopulationImmunologic TestsSensitivity and SpecificityInternal medicinemedicineHumansMass ScreeningeducationSensitivity analyseshealth care economics and organizationsMass screeningAgedGynecologyeducation.field_of_studybiologybusiness.industryHealth PolicyEurosMiddle Agedmedicine.diseasebiology.organism_classificationMarkov Chainsdigestive system diseasesTest (assessment)surgical procedures operativeFecal occult blood screeningOccult BloodIndicators and ReagentsFranceColorectal NeoplasmsGuaiacbusinessInternational Journal of Technology Assessment in Health Care
researchProduct

Mesalazine for the treatment of inflammatory bowel disease

2013

Ulcerative colitis (UC) and Crohn's disease (CD) represent a chronic inflammatory condition of the bowel that often require lifelong medical therapy for the induction and maintenance of the remission. Mesalazine therapies are available both as oral delayed-release and sustained-release formulation, topical formulations and as prodrug.Available literature regarding mesalazine is extensively reviewed in this article, covering its mechanism of action, pharmaceutics and pharmacokinetics, clinical efficacy, safety and tolerability in different settings.Mesalazine has a well-established role in the management of UC. It is the treatment of choice in active and inactive mild-to-moderate UC combinin…

medicine.medical_specialtyColorectal cancerDiseaseGastroenterologyInflammatory bowel diseasechemistry.chemical_compoundCrohn DiseaseMesalazineInternal medicineSecondary PreventionmedicineHumansPharmacology (medical)Intestinal MucosaColitisMesalaminePharmacologyCrohn's diseasebusiness.industryAnti-Inflammatory Agents Non-SteroidalGeneral Medicinemedicine.diseaseUlcerative colitischemistryTolerabilityColitis UlcerativeColorectal NeoplasmsbusinessExpert Opinion on Pharmacotherapy
researchProduct

An unmet medical need:advances in endoscopic imaging of colorectal neoplasia

2011

Gastrointestinal cancer is a major public health problem worldwide. Detection of early neoplastic lesions in gastrointestinal tract is essential for cure, because prognosis and survival are related to the size and stage of malignant lesions. Endoscopic screening and treatment of polyps could prevent approximately 80% of colorectal cancer (CRC). However, white-light endoscopy is an imperfect technology since miss rates of up to 25% have been reported and polyps without malignant potential were treated without benefit but with additional costs and risks to the patient. There are several known "human" predictors of an inadequate colonoscopy. These include patient characteristics such as poor b…

medicine.medical_specialtyEndoscopeColorectal cancerMEDLINEGeneral Physics and AstronomyColonoscopyEndoscopy GastrointestinalGeneral Biochemistry Genetics and Molecular BiologyPhysiciansAnimalsHumansMedicineGeneral Materials ScienceGastrointestinal cancerStage (cooking)Intensive care medicineMicroscopymedicine.diagnostic_testbusiness.industryPublic healthGeneral EngineeringGeneral Chemistrymedicine.diseaseMolecular ImagingSurgeryEndoscopyColorectal Neoplasmsbusiness
researchProduct

European evidence based consensus for endoscopy in inflammatory bowel disease.

2013

Endoscopy plays an essential role in the diagnosis, management, prognosis, and surveillance of inflammatory bowel disease (IBD), but surprisingly there are few available guidelines.1,2 This prompted the ECCO Guidelines Committee (GuiCom) members to promote a Consensus on the appropriate indication and application of different endoscopic modalities in IBD. Since the development of guidelines is an expensive and time-consuming process, this Consensus may help to avoid duplication of effort in the future. It may also identify issues where the evidence is lacking and controlled studies are awaited. The strategy to reach the Consensus involved five steps: 1. Two members of the GuiCom (VA and RE)…

medicine.medical_specialtyEvidence-based practiceColonBiopsyIBDMEDLINEColonic PouchesInflammatory bowel diseaseSeverity of Illness IndexEndoscopy GastrointestinalCrohn's disease (CD)Diagnosis DifferentialColorectal cancer (CRC)IleumMedicineHumansUlcerative colitis (UC)computer.programming_languageModalitiesmedicine.diagnostic_testbusiness.industrydigestive oral and skin physiologyGastroenterologyRectumEndoscopyGeneral MedicineGuidelinemedicine.diseaseInflammatory Bowel Diseasesdigestive system diseasesSurgeryEndoscopyFamily medicinePopulation SurveillanceAcute DiseaseCONSENSUSbusinessWorking groupColorectal NeoplasmscomputerDelphiJournal of Crohn'scolitis
researchProduct

Distribution of Ha-ras alleles in patients with colorectal cancer and Crohn's disease.

1991

The allele distribution of the Ha-ras gene on chromosome 11p was analysed by the restriction fragment length polymorphism of the enzymes Mspl/Hpall in 238 individuals. The investigation covered 116 patients with colorectal carcinoma and 122 patients with Crohn's disease, representing two patient populations with the same ethnic origin, one with a malignant and the other a benign disease of the same organ system. A total of 17 different alleles were detected belonging to the common, intermediate, and rare classes according to the original nomenclature of Ha-ras alleles. Patients with Crohn's disease showed no difference in the distribution of Ha-ras alleles when compared with expected freque…

medicine.medical_specialtyGenotypeColorectal cancerDiseaseBiologyGastroenterologyCrohn DiseasePolymorphism (computer science)Internal medicineGenotypemedicineHumansAlleleAllelesCrohn's diseaseGastroenterologymedicine.diseaseExact testBlotting SouthernGenes rasImmunologyDisease SusceptibilityRestriction fragment length polymorphismColorectal NeoplasmsPolymorphism Restriction Fragment LengthResearch Article
researchProduct

Perioperative chemotherapy versus surgery alone for resectable colorectal liver metastases: an international multicentre propensity score matched ana…

2021

Abstract Background There is still uncertainty regarding the role of perioperative chemotherapy (CTx) in patients with resectable colorectal liver metastases (CRLM), especially in those with a low-risk of recurrence. Methods Multicentre retrospective analysis of patients with CRLM undergoing liver resection between 2010–2015. Patients were divided into two groups according to whether they received perioperative CTx or not and were compared using propensity score matching (PSM) analysis. Then, they were stratified according to prognostic risk scores, including: Clinical Risk Score (CRS), Tumour Burden Score (TBS) and Genetic And Morphological Evaluation (GAME) score. Results The study includ…

medicine.medical_specialtyIndependent predictorResection03 medical and health sciences0302 clinical medicineRisk FactorsPerioperative chemotherapyLong term outcomesmedicineOverall survivalHepatectomyHumansPropensity ScoreRetrospective StudiesHepatologybusiness.industryLiver NeoplasmsGastroenterologyPerioperativePrognosisSurgery030220 oncology & carcinogenesisPropensity score matching030211 gastroenterology & hepatologyNeoplasm Recurrence LocalColorectal NeoplasmsbusinessClinical risk factorHPB
researchProduct

Endoscopic detection of early lower gastrointestinal cancer

2005

The prognosis for patients with malignancies of the lower gastrointestinal tract is strictly dependent on early detection of premalignant and malignant lesions. What should an ideal screening and surveillance colonoscopy be able to accomplish? The technique should allow detection of large but also discrete mucosal alterations. Ideally, endoscopic discrimination between neoplastic and non-neoplastic lesions would be possible during the ongoing procedure. At present, endoscopy can be performed with powerful new endoscopes. Comparable to the rapid development in chip technology, the optical features of the newly designed endoscopes offer resolutions, which allow new surface details to be seen.…

medicine.medical_specialtyMicroscopy ConfocalNarrow-band imagingLower Gastrointestinal TractStaining and Labelingmedicine.diagnostic_testColorectal cancerbusiness.industryGastroenterologyColonoscopyLower Gastrointestinal TractColonoscopymedicine.diseaseChromoendoscopyEndoscopyEarly DiagnosismedicineEndomicroscopyHumansColitis UlcerativeGastrointestinal cancerRadiologyColorectal NeoplasmsbusinessBest Practice & Research Clinical Gastroenterology
researchProduct

Two consecutive clinical trials on cisplatin (CDDP), hepatic arterial infusion (HAI), and I.V. 5-fluorouracil (5-FU) chemotherapy for unresectable co…

1991

Several phase III clinical trials demonstrated that hepatic arterial chemotherapy for unresectable colorectal liver metastases is able to provide significantly higher response rates than those obtained by systemic route: in more than 500 patients collected from 6 randomized trials, the median values of objective response rates were 55% after fluoxuridine (FUdR) continuous hepatic arterial infusion (HAI) vs. 18.5% after FUdR or 5-fluorouracil (5-FU) intravenous (i.v.) chemotherapy. Furthermore, the majority of those studies reported that median survival increased in the patient subgroups treated with intrahepatic chemotherapy, even if not always statistically significant [1-6]. Certainly, FU…

medicine.medical_specialtyOrganoplatinum Compoundsmedicine.medical_treatmentPhases of clinical researchRectumGastroenterologyMetastasisHepatic arterial infusionInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansInfusions Intra-ArterialCisplatinChemotherapybusiness.industryLiver NeoplasmsGeneral MedicineMiddle Agedmedicine.diseaseSurgerySurvival RateClinical trialmedicine.anatomical_structureOncologyFluorouracilDrug EvaluationSurgeryFluorouracilColorectal NeoplasmsFloxuridinebusinessmedicine.drugJournal of Surgical Oncology
researchProduct

European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full Supplement publication

2013

Population-based screening for early detection and treatment of colorectal cancer (CRC) and precursor lesions, using evidence-based methods, can be effective in populations with a significant burden of the disease provided the services are of high quality. Multidisciplinary, evidence-based guidelines for quality assurance in CRC screening and diagnosis have been developed by experts in a project co-financed by the European Union. The 450-page guidelines were published in book format by the European Commission in 2010. They include 10 chapters and over 250 recommendations, individually graded according to the strength of the recommendation and the supporting evidence. Adoption of the recomme…

medicine.medical_specialtyPathologyCIENCIAS MÉDICAS Y DE LA SALUDQuality Assurance Health CareSettore MED/18 - CHIRURGIA GENERALEPopulationMEDLINECiencias de la SaludScientific literatureCOLON CANCERGUIDELINESArticle//purl.org/becyt/ford/3.3 [https]SDG 3 - Good Health and Well-beingHealth caremedicinemedia_common.cataloged_instanceQUALITYHumansMass ScreeningMedical physicsEuropean unioneducationMass screeningEarly Detection of Cancermedia_commoneducation.field_of_studyEvidence-Based Medicinebusiness.industryGastroenterologyÉtica MédicaEvidence-based medicineSCREENINGHealth CareEurope//purl.org/becyt/ford/3 [https]colorectal cancer screening; guidelines; quality assurancebusinessQuality AssuranceColorectal NeoplasmsQuality assurance
researchProduct